Literature DB >> 19948632

The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.

H Cody Meissner1, Joseph A Bocchini, Michael T Brady, Caroline B Hall, David W Kimberlin, Larry K Pickering.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948632     DOI: 10.1542/peds.2009-2346

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  5 in total

1.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

2.  Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.

Authors:  Sumanta Mukherjee; Nicholas W Lukacs
Journal:  Expert Rev Anti Infect Ther       Date:  2010-06       Impact factor: 5.091

3.  Detection of respiratory syncytial virus using nanoparticle amplified immuno-polymerase chain reaction.

Authors:  Jonas W Perez; Elizabeth A Vargis; Patricia K Russ; Frederick R Haselton; David W Wright
Journal:  Anal Biochem       Date:  2010-11-25       Impact factor: 3.365

4.  Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis.

Authors:  Steven B Smith; William Dampier; Aydin Tozeren; James R Brown; Michal Magid-Slav
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

5.  Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.

Authors:  Maarten O Blanken; Hendrik Koffijberg; Elisabeth E Nibbelke; Maroeska M Rovers; Louis Bont
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.